{"schema_version":"secwatch.filing_event.v1","accession":"0001077183-25-000007","form_type":"8-K","ticker":"NEO","cik":"0001077183","company_name":"NEOGENOMICS INC","filed_at":"2025-01-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:02.878591+00:00","generated_at":"2026-05-28T00:48:28.027899+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"NeoGenomics guides 2025 revenue $735-745M, adj. EBITDA $55-58M; issues retention bonuses","bullets":["2025 revenue guidance $735-745M (midpoint $740M) vs FY24 $661M, ~12% YoY growth.","2025 adjusted EBITDA guidance $55-58M vs FY24 $38.5M, up 43-51%.","Long-range plan: 12-13% annual revenue growth; NGS growth ~25% per year.","Retention bonuses: CFO Sherman ($400K cash + $750K RSUs), Presidents Harris and Stone each similar with vesting thru 2026.","Expects to retire 2025 convertible notes due May 1 with cash on hand."],"urls":{"canonical":"https://secwatch.observer/filing/0001077183-25-000007","json":"https://secwatch.observer/filing/0001077183-25-000007.json","markdown":"https://secwatch.observer/filing/0001077183-25-000007.md","text":"https://secwatch.observer/filing/0001077183-25-000007.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1077183/000107718325000007/0001077183-25-000007-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1077183/000107718325000007/neo-20250114.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T00:48:28.027899+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}